Researchers restore immune responses and clear tumors in experiments


Blocking production or signaling of PGE2 restored anticancer immune responses when researchers induced cancer-cell death called ferroptosis. The preclinical findings point to a possible way to investigate cancer treatment.
Researchers found that blocking a signal produced by dying cancer cells restored an anticancer immune response and led to tumor elimination in preclinical experiments. The signal, prostaglandin E2 (PGE2), is a lipid molecule that can affect how cells respond to their surroundings.
The team induced ferroptosis, a form of cell death caused by extensive oxidation of fats in cell membranes. Earlier mouse studies had shown that clearing tumors this way depends on immune cells, but that dying cells can also suppress the response. The new study links that suppression to PGE2.
The study, published in Nature on 18 November 2026, lists Lukas Ramsauer as first author. Co-author Jan P. Böttcher leads a lab at the Institute of Molecular Immunology at TUM and is a professor and department head at University Hospital Tübingen.
The researchers found that oxidized membrane fats allowed calcium to enter cells undergoing ferroptosis. Calcium activated a signaling pathway called p38 MAPK, which increased the enzyme COX-2 and drove PGE2 production. In cell experiments, inhibiting COX or p38 MAPK blocked PGE2 production without preventing ferroptotic death.
PGE2 impaired type 1 conventional dendritic cells, or cDC1s, which help activate cancer-fighting CD8+ T cells. In a lab experiment, liquid containing substances released by ferroptotic mouse melanoma cells reduced the cDC1s’ production of CXCL9 and IL-12, molecules that support T-cell responses. Liquid from cells undergoing apoptosis or doxorubicin-induced immunogenic cell death did not have the same effect.

Researchers estimate that islands hold about 20% of the world’s roughly 21,000 described bee species, although they cover about 6% of its land. The inventory maps where island bees live and can guide conservation research.
PGE2 acts in part by binding to receptors called EP2 and EP4. In 2023, Böttcher and colleagues reported that tumor-derived PGE2 impaired cDC1s; his lab says targeting those receptors prevented the dysfunction and restored the cells’ coordination of T-cell responses.
The team also induced ferroptosis with RSL3 in pancreatic cancer cells taken from patients and found increased PGE2 production in the lab. That experiment measured the cells’ response; it did not establish tumor clearance in patients.
The researchers say the pathway could potentially be used for cancer therapy. Whether combining ferroptosis induction with PGE2 blockade would be safe or effective in patients, and when it might be tested in them, remains unknown.
3 min

Flight-arena experiments found that the migrating moths use the tilt of magnetic field lines to find their seasonal direction, offering an explanation for how they steer when stars are hidden.
3 min

Z. Wang and colleagues induced a reversible structural change in a graphene–boron nitride stack, accompanied by a switch between discrete charge levels. The experiment gives researchers a way to study how strain and electrical charge interact.
3 min